Taxanes in combined modality therapy for solid tumors
- 7 March 2001
- journal article
- review article
- Published by Elsevier BV in Critical Reviews in Oncology/Hematology
- Vol. 37 (3), 237-247
- https://doi.org/10.1016/s1040-8428(00)00112-8
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- 914: Improved survival using fractionated stereotactic radiosurgery (FSR) and concurrent taxol (T) for recurrent glioblastoma multiforme (RGM)European Journal Of Cancer, 1997
- 284 Induction paclitaxel (TAXOL) and carboplatin (CBDCA) followed by concurrent chemoradiotherapy (TRT-CT) in unresectable, locally advanced non-small cell lung carcinoma (NSCLC): Report of FCCC 94-001Lung Cancer, 1997
- Paclitaxel as a radiosensitiser: A proposed schedule of administration based on in vitro data and pharmacokinetic calculationsEuropean Journal Of Cancer, 1997
- Enhanced acute toxicity in oropharynx carcinoma treated with radiotherapy and concomitant cisplatin, 5-fluorouracil and mitomycin CEuropean Journal Of Cancer, 1996
- Relationship of Mitotic Arrest and Apoptosis to Antitumor Effect of PaclitaxelJNCI Journal of the National Cancer Institute, 1996
- In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma cell linesCancer, 1996
- Docetaxel in stage III and IV non-small cell lung cancerEuropean Journal Of Cancer, 1995
- Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancerCancer, 1995
- Polychemotherapy in advanced non small cell lung cancer: a meta-analysisThe Lancet, 1993
- Swallowing function in patients with esophageal cancer treated with concurrent radiation and chemotherapyCancer, 1993